Lacey, Charles J

Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.

McCormack, S., Dunn, D. T., Desai, M., Dolling, D. I., Gafos, M., Gilson, R., Sullivan, A. K., Clarke, A., Reeves, I., Schembri, G., et al. (2016) · The Lancet

HIV/AIDS Research and InterventionsHIV/AIDS drug development and treatment

Cited by 1,878

PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial.

McCormack, S., Ramjee, G., Kamali, A., Rees, H., Crook, A. M., Gafos, M., Jentsch, U., Pool, R., Chisembele, M., Kapiga, S., et al. (2010) · The Lancet

HIV/AIDS Research and InterventionsHIV/AIDS drug development and treatment

Cited by 335

Characteristics of autoimmune thyroid disease occurring as a late complication of immune reconstitution in patients with advanced human immunodeficiency virus (HIV) disease

Chen, F., Day, S. L., Metcalfe, R. A., Sethi, G., Kapembwa, M. S., Brook, M. G., Churchill, D., de Ruiter, A., Robinson, S., Lacey, C. J., et al. (2005) · Medicine

Thyroid Disorders and TreatmentsHIV Research and Treatment

Cited by 142

An analysis of baseline data from the PROUD study: an open-label randomised trial of pre-exposure prophylaxis.

On behalf of the PROUD Study Group, Dolling, D. I., Desai, M., McOwan, A., Gilson, R., Clarke, A., Fisher, M., Schembri, G., Sullivan, A. K., Mackie, N., et al. (2016) · Trials

HIV/AIDS Research and InterventionsHIV, Drug Use, Sexual Risk

Cited by 51

Chronic microsporidian infection of the nasal mucosae, sinuses and conjunctivae in HIV disease.

Lacey, C. J., Clarke, A. M., Fraser, P., Metcalfe, T., Bonsor, G., & Curry, A. (1992) · Sexually Transmitted Infections

Parasitic Infections and DiagnosticsOcular Infections and Treatments

Cited by 45